Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pear Tree Pharmaceuticals, Inc.

Latest From Pear Tree Pharmaceuticals, Inc.

'Breakthrough' status granted to Aimmune's peanut allergy drug

The FDA has granted breakthrough therapy designation (BTD) to Aimmune Therapeutics' investigational oral immunotherapy for peanut allergy, known as AR101.

Immune Disorders

21st Century Cures leaders vow to work out differences

The two members of the House who have been leading an effort to overhaul certain functions at the FDA and the National Institutes of Health and other areas of the US biomedical research and development enterprise wit the goal of accelerating the discovery, development and delivery of medical therapies have vowed to work out their differences and move the legislative process forward.

ZMapp, 'modern techniques' too late to save doctor

The death of a doctor who was being treated for Ebola in the US with the best of what medical care has to offer, including the hard-to-obtain experimental drug ZMapp, was a stark reminder that in the very advanced stages, even the most modern techniques are not enough to save a patient's life when they reach a critical threshold, said Dr Jeff Gold, chancellor of the University of Nebraska Medical Center (UNMC) in Omaha.

Immune Disorders Sierra Leone

US Capitol Capsule: Another US healthcare crisis: VA woes go beyond wait times

It's been a rough year for healthcare under the Obama administration – first with the botched launch of the Affordable Care Act insurance exchanges, and now with a scandal involving falsified records of patient wait times at medical facilities operated by the Veterans Health Administration (VHA), which is likely to linger throughout the time the president has left at the White House.

Neurology
See All

Company Information

UsernamePublicRestriction

Register